查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830907

2025年综合多重诊断全球市场报告

Syndromic Multiplex Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，症候群多重诊断市场快速扩张，市场规模从2024年的31.1亿美元成长至2025年的34.3亿美元，复合年增长率达10.0%。推动这一增长的因素包括：对快速精准诊断的需求不断增长、人们对早期疾病检测的认识不断提高、医院内感染髮病率不断上升、分子诊断的广泛应用、医疗保健支出不断增长以及对就地检验的需求不断增长。

预计未来几年综合症多重诊断市场规模将强劲成长，到 2029 年将达到 49.6 亿美元，复合年增长率为 9.7%。预测期内的成长可归因于研发投资的增加、资源匮乏环境中采用率的提高、开发中国家医疗基础设施的扩大、政府抗击感染疾病的倡议的增多以及对分散式检查的需求的增加。预测期内的主要趋势包括多重聚合酵素链锁反应(PCR) 技术的进步、微流体和实验室晶片系统的创新、样品处理自动化程度的提高、照护现场分子平台的开发、云端基础的诊断数据系统的整合以及携带式诊断设备的进步。

综合征多重诊断是一种分子检测方法，可从单一患者样本同时检测和鑑定与特定综合征相关的多种病原体或生物标记。此方法采用多重聚合酵素链锁反应(PCR) 或同等技术，提供快速且全面的结果。透过一次性识别多种潜在病因，这些诊断方法有助于及时准确地诊断感染疾病，从而改善临床决策和患者预后。

综合征多重诊断的主要产品类型包括仪器、试剂、软体和服务。综合征多重诊断设备是先进的分子检测系统，旨在使用即时聚合酵素链锁反应(PCR) 和微流体等整合平台同时检测单一患者样本中的多种病原体，从而快速准确地诊断疾病。分析的样本类型包括血液、尿液、唾液和组织。这些诊断方法采用多种技术，包括聚合酵素链锁反应(PCR)、质谱、核酸增幅检查和次世代定序，并应用于感染疾病、性行为感染和中枢神经系统疾病等领域。最终用户包括临床实验室、医院、製药和生物技术公司以及研究机构。

2025年春季美国关税的突然上调以及随之而来的贸易摩擦对医疗设备行业产生了重大影响，尤其对进口诊断影像设备零件、手术用不銹钢和塑胶耗材产生了重大影响。医院和诊所抵制涨价，挤压了製造商的净利率。监管障碍加剧了这个问题，因为与关税相关的供应商变更通常需要设备重新认证，从而延缓了产品上市时间。企业正在透过双重采购关键零件、扩大国内商品化生产以及加快高性价比材料的研发来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供综合征多重诊断市场统计数据，例如全球市场规模、区域份额、综合征多重诊断市场份额的竞争对手、详细的综合征多重诊断细分市场、市场趋势以及综合征多重诊断行业的商机，为您提供在综合征多重诊断行业取得成功所需的数据。本综合征多重诊断市场研究报告对该行业的现状和未来情况进行了详细分析，为您提供所需的一切资讯的完整展望。

预计感染疾病多重诊断率的上升将在未来几年推动综合征多重诊断市场的成长。当细菌、病毒、真菌和寄生虫等有害微生物侵入人体并在体内繁殖时，就会发生感染疾病，从而引起各种症状和健康併发症。感染疾病的增加主要是由于全球旅行的增加，这促进了病原体跨境和跨人群传播。综合征多重诊断透过从单一样本中快速同时检测多种病原体来支持感染疾病管理。这些诊断方法提高了诊断的速度和准确性，从而能够及时做出治疗决策并改善患者的预后。例如，2023 年 3 月，美国国家公共卫生机构疾病管制与预防中心报告 2022 年有 8,331 例结核病病例，比 2021 年的 7,874 例增加了 5.9%。因此，感染疾病的增加促进了综合征多重诊断市场的扩张。

综合征多重诊断领域的主要企业正专注于开发技术先进的解决方案，包括基于人工智慧的诊断演算法，以提高病原体检测的速度、准确性和广度。基于人工智慧的诊断演算法是一种先进的计算工具，它利用人工智慧（尤其是机器学习和深度学习技术）分析复杂的临床和实验室数据，从而更快、更准确地诊断疾病。例如，2024年1月，总部位于荷兰的分子诊断公司Qiagen NV为其QIAstat-Dx平台推出了两种综合征检测组合：胃肠道组合2和脑膜炎和脑炎组合。这些组合可以在一次检测中快速准确地检测多种病原体，从而辅助临床决策并改善患者预后。 QIAstat-Dx系统还整合了先进的数据分析功能，帮助医护人员有效率地识别和管理感染疾病疫情。

2022年6月，总部位于德国的生技公司R Biopharm AG收购了AusDiagnostics Pty Ltd.，收购金额未揭露。 R Biopharm旨在透过此次收购扩大产品系列，进军新的临床诊断细分市场，加速其国际成长策略，并成为全球公认的跨地区临床实验室诊断系统供应商。 AusDiagnostics Pty Ltd.总部位于澳大利亚，专注于体外诊断（IVD）和综合多重诊断。

综合征多重诊断市场由提供诊断工作流程整合服务、远端检测、用于综合征检测的临床决策支援工具以及诊断实验室的法规和合规性支援等服务的营业单位所获得的收益构成。市场价值包括服务供应商销售的或包含在其服务产品中的相关产品的价值。综合征多重诊断市场还包括用于同时检测多种病原体的多重诊断仪器、试剂、耗材、软体和配件的销售。此市场的价值代表“出厂价”，即产品製造商或创造者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场中的产品价值还包括产品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球症候群多重诊断：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球症候群多重诊断市场：成长率分析
  • 全球症候群多重诊断市场表现：规模与成长，2019-2024
  • 全球症候群多重诊断市场预测：规模与成长，2024-2029 年，2034 年
  • 全球症候群多重诊断：总目标市场（TAM）

第六章 市场细分

  • 全球症候群多重诊断市场（依产品类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 试剂
  • 软体和服务
  • 全球症候群多重诊断市场（依样本类型、实际及预测），2019-2024 年、2024-2029 年、2034 年
  • 血液样本
  • 尿液样本
  • 唾液样本
  • 组织样本
  • 全球症候群多重诊断市场：依技术、绩效与预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素链锁反应
  • 质谱法
  • 核酸增幅检查
  • 次世代定序
  • 全球症候群多重诊断市场：依应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 感染疾病
  • 呼吸系统疾病
  • 消化系统疾病
  • 性行为感染传染病
  • 中枢神经系统疾病
  • 全球综合症多重诊断市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 临床实验室
  • 医院
  • 製药和生物技术公司
  • 研究机构
  • 其他最终用户
  • 全球症候群多重诊断市场：依设备类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 即时聚合酵素链锁反应（PCR）系统
  • 基于微流体的系统
  • 自动化样本到答案系统
  • 基于墨盒的系统
  • 多重聚合酵素链锁反应（PCR）平台
  • 全球症候群多重诊断市场：按试剂类型、效能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 检测组
  • 引子和探针
  • 酵素
  • 缓衝液和溶液
  • 样品製备试剂
  • 全球症候群多重诊断市场：按软体和服务细分（按类型）、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 数据分析软体
  • 云端基础的诊断平台
  • 整合和连接解决方案
  • 技术支援服务
  • 维护和校准服务
  • 培训及安装服务

第七章 区域和国家分析

  • 全球症候群多重诊断市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球症候群多重诊断市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 症候群多重诊断市场：竞争格局
  • 症候群多重诊断市场：公司简介
    • Roche Molecular Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Qiagen NV
  • Cepheid
  • Bosch Healthcare Solutions GmbH
  • Biocartis NV
  • Luminex Corporation
  • Curetis GmbH
  • Accelerate Diagnostics Inc.
  • Applied BioCode Inc.
  • Ador Diagnostics Ltd.
  • Akonni Biosystems Inc.
  • Alveo Technologies Inc.
  • Atlas Genetics Ltd.
  • BioFire Diagnostics LLC
  • Nanomix Inc.
  • Primerdesign Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年症候群多重诊断市场：提供新机会的国家
  • 2029年症候群多重诊断市场：细分市场带来新机会
  • 2029年症候群多重诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r37898

Syndromic multiplex diagnostics is a molecular testing approach that simultaneously detects and identifies multiple pathogens or biomarkers linked to a particular syndrome from a single patient sample. This approach employs multiplex polymerase chain reaction (PCR) or comparable technologies to provide rapid and comprehensive results. By identifying multiple potential causes at once, these diagnostics support timely and accurate diagnosis of infectious diseases, enhancing clinical decision-making and patient outcomes.

The primary product categories in syndromic multiplex diagnostics include instruments, reagents, software, and services. Syndromic multiplex diagnostic instruments are sophisticated molecular testing systems designed to detect multiple pathogens simultaneously from a single patient sample, using integrated platforms such as real-time polymerase chain reaction (PCR) or microfluidics for fast and precise disease diagnosis. The types of samples analyzed include blood, urine, saliva, and tissue. These diagnostics employ various technologies, including polymerase chain reaction (PCR), mass spectrometry, nucleic acid amplification tests, and next-generation sequencing, and are applied in areas such as infectious diseases, respiratory diseases, gastrointestinal diseases, sexually transmitted infections, and central nervous system diseases. Their end users include clinical laboratories, hospitals, pharmaceutical and biotechnology companies, research institutes, and other organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The syndromic multiplex diagnostics market research report is one of a series of new reports from The Business Research Company that provides syndromic multiplex diagnostics market statistics, including the syndromic multiplex diagnostics industry global market size, regional shares, competitors with the syndromic multiplex diagnostics market share, detailed syndromic multiplex diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the syndromic multiplex diagnostics industry. This syndromic multiplex diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The syndromic multiplex diagnostics market size has grown rapidly in recent years. It will grow from $3.11 billion in 2024 to $3.43 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth observed during the historic period can be attributed to the increasing demand for rapid and precise diagnostics, greater awareness of early disease detection, a rise in hospital-acquired infections, wider adoption of molecular diagnostics, higher healthcare spending, and an expanding need for point-of-care testing.

The syndromic multiplex diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth during the forecast period can be attributed to increasing investments in research and development, greater adoption in low-resource settings, expanding healthcare infrastructure in developing countries, rising government initiatives for infectious disease control, and growing demand for decentralized testing. Key trends in the forecast period include advancements in multiplex polymerase chain reaction (PCR) technologies, innovations in microfluidics and lab-on-chip systems, enhanced automation in sample processing, development of point-of-care molecular platforms, integration of cloud-based diagnostic data systems, and progress in portable diagnostic devices.

The rising prevalence of infectious diseases is anticipated to drive growth in the syndromic multiplex diagnostics market in the coming years. Infectious diseases are caused by harmful microorganisms, including bacteria, viruses, fungi, or parasites, which invade the body, multiply, and cause various symptoms and health complications. The increase in infectious diseases is largely attributed to growing global travel, which facilitates the spread of pathogens across borders and populations. Syndromic multiplex diagnostics support infectious disease management by enabling the rapid and simultaneous detection of multiple pathogens from a single sample. These diagnostics enhance both the speed and accuracy of diagnosis, allowing for timely treatment decisions and improved patient outcomes. For example, in March 2023, the Centers for Disease Control and Prevention, a national public health organization in the United States, reported 8,331 cases of tuberculosis (TB) in 2022, marking a 5.9% rise from 7,874 cases in 2021. Consequently, the growing prevalence of infectious diseases is contributing to the expansion of the syndromic multiplex diagnostics market.

Leading companies in the syndromic multiplex diagnostics sector are concentrating on developing technologically advanced solutions, including AI-powered diagnostic algorithms, to improve the speed, accuracy, and breadth of pathogen detection. AI-enhanced diagnostic algorithms are sophisticated computational tools that use artificial intelligence, particularly machine learning and deep learning methods, to analyze complex clinical and laboratory data for faster and more precise disease diagnosis. For instance, in January 2024, Qiagen N.V., a molecular diagnostics company based in the Netherlands, launched two syndromic testing panels, the Gastrointestinal Panel 2 and the Meningitis and Encephalitis Panel for its QIAstat Dx platform. These panels allow rapid and accurate detection of multiple pathogens in a single test, aiding clinical decision-making and improving patient outcomes. The QIAstat-Dx system also incorporates advanced data analytics, helping healthcare professionals efficiently identify and manage infectious disease outbreaks.

In June 2022, R Biopharm AG, a biotechnology company based in Germany, acquired AusDiagnostics Pty Ltd. for an undisclosed sum. Through this acquisition, R Biopharm aims to expand its product portfolio, enter new clinical diagnostics market segments, and accelerate its international growth strategy, positioning itself as a globally recognized system supplier in laboratory diagnostics across multiple regions. AusDiagnostics Pty Ltd., headquartered in Australia, specializes in in vitro diagnostics (IVD) and syndromic multiplex diagnostics.

Major players in the syndromic multiplex diagnostics market are Roche Molecular Systems Inc., Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Cepheid, Bosch Healthcare Solutions GmbH, Biocartis NV, Luminex Corporation, Curetis GmbH, Accelerate Diagnostics Inc., Applied BioCode Inc., Ador Diagnostics Ltd., Akonni Biosystems Inc., Alveo Technologies Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, Nanomix Inc., Primerdesign Ltd.

North America was the largest region in the syndromic multiplex diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in syndromic multiplex diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the syndromic multiplex diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The syndromic multiplex diagnostics market consists of revenues earned by entities by providing services such as diagnostic workflow integration services, remote testing, clinical decision support tools for syndromic testing, and regulatory and compliance support for diagnostic labs. The market value includes the value of related goods sold by the service provider or included within the service offering. The syndromic multiplex diagnostics market also includes sales of multiplex diagnostic instruments, reagents and consumables, software, and accessories used for the simultaneous detection of multiple pathogens. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Syndromic Multiplex Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on syndromic multiplex diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for syndromic multiplex diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The syndromic multiplex diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Instruments; Reagents; Software And Services
  • 2) By Sample Type: Blood Samples; Urine Samples; Saliva Samples; Tissue Samples
  • 3) By Technology: Polymerase Chain Reaction; Mass Spectrometry; Nucleic Acid Amplification Tests; Next-Generation Sequencing
  • 4) By Application: Infectious Diseases; Respiratory Diseases; Gastrointestinal Diseases; Sexually Transmitted Infections; Central Nervous System Diseases
  • 5) By End User: Clinical Laboratories; Hospitals; Pharmaceutical And Biotechnology Companies; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Instruments: Real-Time Polymerase Chain Reaction (PCR) Systems; Microfluidic-Based Systems; Automated Sample-To-Answer Systems; Cartridge-Based Systems; Multiplex Polymerase Chain Reaction (PCR) Platforms
  • 2) By Reagents: Assay Panels; Primers And Probes; Enzymes; Buffers And Solutions; Sample Preparation Reagents
  • 3) By Software And Services: Data Analysis Software; Cloud-Based Diagnostic Platforms; Integration And Connectivity Solutions; Technical Support Services; Maintenance And Calibration Services; Training And Installation Services
  • Companies Mentioned: Roche Molecular Systems Inc.; Abbott Laboratories; Becton Dickinson and Company; Hologic Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Cepheid; Bosch Healthcare Solutions GmbH; Biocartis NV; Luminex Corporation; Curetis GmbH; Accelerate Diagnostics Inc.; Applied BioCode Inc.; Ador Diagnostics Ltd.; Akonni Biosystems Inc.; Alveo Technologies Inc.; Atlas Genetics Ltd.; BioFire Diagnostics LLC; Nanomix Inc.; Primerdesign Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Syndromic Multiplex Diagnostics Market Characteristics

3. Syndromic Multiplex Diagnostics Market Trends And Strategies

4. Syndromic Multiplex Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Syndromic Multiplex Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Syndromic Multiplex Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Syndromic Multiplex Diagnostics Market Growth Rate Analysis
  • 5.4. Global Syndromic Multiplex Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Syndromic Multiplex Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Syndromic Multiplex Diagnostics Total Addressable Market (TAM)

6. Syndromic Multiplex Diagnostics Market Segmentation

  • 6.1. Global Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents
  • Software And Services
  • 6.2. Global Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Samples
  • Urine Samples
  • Saliva Samples
  • Tissue Samples
  • 6.3. Global Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction
  • Mass Spectrometry
  • Nucleic Acid Amplification Tests
  • Next-Generation Sequencing
  • 6.4. Global Syndromic Multiplex Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Diseases
  • Respiratory Diseases
  • Gastrointestinal Diseases
  • Sexually Transmitted Infections
  • Central Nervous System Diseases
  • 6.5. Global Syndromic Multiplex Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Laboratories
  • Hospitals
  • Pharmaceutical And Biotechnology Companies
  • Research Institutes
  • Other End Users
  • 6.6. Global Syndromic Multiplex Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Real-Time Polymerase Chain Reaction (PCR) Systems
  • Microfluidic-Based Systems
  • Automated Sample-To-Answer Systems
  • Cartridge-Based Systems
  • Multiplex Polymerase Chain Reaction (PCR) Platforms
  • 6.7. Global Syndromic Multiplex Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Assay Panels
  • Primers And Probes
  • Enzymes
  • Buffers And Solutions
  • Sample Preparation Reagents
  • 6.8. Global Syndromic Multiplex Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Cloud-Based Diagnostic Platforms
  • Integration And Connectivity Solutions
  • Technical Support Services
  • Maintenance And Calibration Services
  • Training And Installation Services

7. Syndromic Multiplex Diagnostics Market Regional And Country Analysis

  • 7.1. Global Syndromic Multiplex Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Syndromic Multiplex Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Syndromic Multiplex Diagnostics Market

  • 8.1. Asia-Pacific Syndromic Multiplex Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Syndromic Multiplex Diagnostics Market

  • 9.1. China Syndromic Multiplex Diagnostics Market Overview
  • 9.2. China Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Syndromic Multiplex Diagnostics Market

  • 10.1. India Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Syndromic Multiplex Diagnostics Market

  • 11.1. Japan Syndromic Multiplex Diagnostics Market Overview
  • 11.2. Japan Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Syndromic Multiplex Diagnostics Market

  • 12.1. Australia Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Syndromic Multiplex Diagnostics Market

  • 13.1. Indonesia Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Syndromic Multiplex Diagnostics Market

  • 14.1. South Korea Syndromic Multiplex Diagnostics Market Overview
  • 14.2. South Korea Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Syndromic Multiplex Diagnostics Market

  • 15.1. Western Europe Syndromic Multiplex Diagnostics Market Overview
  • 15.2. Western Europe Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Syndromic Multiplex Diagnostics Market

  • 16.1. UK Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Syndromic Multiplex Diagnostics Market

  • 17.1. Germany Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Syndromic Multiplex Diagnostics Market

  • 18.1. France Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Syndromic Multiplex Diagnostics Market

  • 19.1. Italy Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Syndromic Multiplex Diagnostics Market

  • 20.1. Spain Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Syndromic Multiplex Diagnostics Market

  • 21.1. Eastern Europe Syndromic Multiplex Diagnostics Market Overview
  • 21.2. Eastern Europe Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Syndromic Multiplex Diagnostics Market

  • 22.1. Russia Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Syndromic Multiplex Diagnostics Market

  • 23.1. North America Syndromic Multiplex Diagnostics Market Overview
  • 23.2. North America Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Syndromic Multiplex Diagnostics Market

  • 24.1. USA Syndromic Multiplex Diagnostics Market Overview
  • 24.2. USA Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Syndromic Multiplex Diagnostics Market

  • 25.1. Canada Syndromic Multiplex Diagnostics Market Overview
  • 25.2. Canada Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Syndromic Multiplex Diagnostics Market

  • 26.1. South America Syndromic Multiplex Diagnostics Market Overview
  • 26.2. South America Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Syndromic Multiplex Diagnostics Market

  • 27.1. Brazil Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Syndromic Multiplex Diagnostics Market

  • 28.1. Middle East Syndromic Multiplex Diagnostics Market Overview
  • 28.2. Middle East Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Syndromic Multiplex Diagnostics Market

  • 29.1. Africa Syndromic Multiplex Diagnostics Market Overview
  • 29.2. Africa Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Syndromic Multiplex Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Syndromic Multiplex Diagnostics Market Competitive Landscape
  • 30.2. Syndromic Multiplex Diagnostics Market Company Profiles
    • 30.2.1. Roche Molecular Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Syndromic Multiplex Diagnostics Market Other Major And Innovative Companies

  • 31.1. Qiagen N.V.
  • 31.2. Cepheid
  • 31.3. Bosch Healthcare Solutions GmbH
  • 31.4. Biocartis NV
  • 31.5. Luminex Corporation
  • 31.6. Curetis GmbH
  • 31.7. Accelerate Diagnostics Inc.
  • 31.8. Applied BioCode Inc.
  • 31.9. Ador Diagnostics Ltd.
  • 31.10. Akonni Biosystems Inc.
  • 31.11. Alveo Technologies Inc.
  • 31.12. Atlas Genetics Ltd.
  • 31.13. BioFire Diagnostics LLC
  • 31.14. Nanomix Inc.
  • 31.15. Primerdesign Ltd.

32. Global Syndromic Multiplex Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Syndromic Multiplex Diagnostics Market

34. Recent Developments In The Syndromic Multiplex Diagnostics Market

35. Syndromic Multiplex Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Syndromic Multiplex Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Syndromic Multiplex Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Syndromic Multiplex Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer